Llwytho...
Personalising your health: an EU imperative
In the fast-moving world of personalised medicine there are many issues and barriers—not least when it comes to getting novel drugs and treatments swiftly to where they are really needed. Slow bench-to-bedside rates do not help the 500 million potential patients across the EU’s current 28 Member Sta...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ecancermedicalscience |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cancer Intelligence
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533597/ https://ncbi.nlm.nih.gov/pubmed/28798813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2017.ed68 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|